[1]
|
M. F. Swiontkowski, “Laser Doppler Flowmetry - De- velopment and Clinical Application”, Lowa Orthop J, Vol. 11, 1991, pp. 119-126.
|
[2]
|
A. HSandner-KieslingH, G. HLitscherH, HH. Voit-AugustinH, H R. L. JamesH and G.H SchwarzH, “Laser Doppler Flowmetry in Combined Needle Acupuncture and Moxibustion: A Pilot Study in Healthy Adults”, Lasers Med Sci, Vol. 16, No. 3, 2001, pp. 184-191.
|
[3]
|
J. Dirks, P. Fabricius, K. L. Petersen, M. C. Rowbotham and J. B. Dahl, “The effect of systemic lidocaine on pain and secondary hyperalgesia associated with heat/capsai- cin sensitization model in healthy volunteers”, Anesth Analg, Vol. 91, No. 4, 2000, pp. 967-972.
|
[4]
|
K. L. Petersen and M. C. Rowbotham, “A new human experimental pain model: the heat/capsaicin sensitization model”, NeuroReport, Vol. 10, No. 7, 1999, pp. 1511- 1516.
|
[5]
|
K. L. Petersen, B. Jones, V. Segredo, J. B. Dahl and M .C. Rowbotham, “Effect of Remifentanil on pain and sec- ondary hyperalgesia associated with the heat-capsaicin sensitization model in healthy volunteers”, Anesthesiol- ogy, Vol. 94, No. 1, 2001, pp. 15-20.
|
[6]
|
H. Sumikura, O. K. Andersen, A. M. Drewes and L. Ar- endt-Nielsen, “Spatial and temporal profiles of flare and hyperalgesia after intradermal capsaicin”, Pain, Vol. 105, No. 1-2, 2003, pp. 285-291.
|
[7]
|
R. D. Helme and S. McKernan, “Neurogenic flare re- sponses following topical application of capsaicin in hu- mans”, Ann Neurol, Vol. 18, No. 4, 1985, pp. 505-509.
|
[8]
|
S. R. Hughes and S. D. Brain, “A calcitonin gene-related peptide (CGRP) antagonist (CGRP8-37) inhibits mi- crovascular responses induced by CGRP and capsaicin in skin”, Br J Pharmacol, Vol. 104, No. 3, 1991, pp. 738- 742.
|
[9]
|
P. Holzer, “Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons”, Phar- macol Rev, Vol. 43, No. 2, 1991, pp. 143-201.
|
[10]
|
R. G. Roberts, R. A. Westerman, R. E. Widdop, R. R. Kotzmann and R. Payne, “Effects of capsaicin on cuta- neous vasodilator responses in humans”, Agents Actions, Vol. 37, No. 1-2, 1992, pp. 53-59.
|
[11]
|
D. A. Simone and J. Ochoa, “Early and late effects of prolonged topical capsaicin on cutaneous sensibility and neurogenic vasodilatation in humans”, Pain, Vol. 47, No. 3, 1991, pp. 285-294.
|
[12]
|
D. P. Stephens, N. Charkoudian, J. M. Benevento, J. M. Johnson and J. L. Saumet, “The influence of topical cap- saicin on the local thermal control of skin blood flow in humans”, Am J Physiol Reg Integr Comp Physiol, Vol. 281, No. 3, 2001, pp. R894-R901.
|
[13]
|
S. D. Brain and T. J. Williams, “Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability”, Br J Pharmacol, Vol. 86, Vol. 4, 1985, pp. 855-860.
|
[14]
|
M. K. Herbert, R. Tafler, R. F. Schmidt and K. H. Weis, “Cyclooxygenase inhibitors acetylsalicylic acid and in- domethacin do not affect capsaicin-induced neurogenic inflammation in human skin”, Agents Actions, Vol. 38, 1993, pp. C25-C27.
|
[15]
|
M. Huttunen, I. T. Harvima, L. Ackermann, R. J. Har- vima, A. Naukkarinen and M. Horsmanheimo, “Neu- ropeptide- and capsaicin-induced histamine release in skin monitored with the microdialysis technique”, Acta Derm Venereol, Vol. 76, No. 3, 1996, pp. 205-209.
|
[16]
|
L. J. Petersen, K. Winge, E. Brodin and P. S. Skov, “No release of histamine and substance P in capsaicin-induced neurogenic inflammation in intact human skin in vivo: a microdialysis study”, Clin Exp Allergy, Vol. 27, No. 8, 1997, 957-965.
|
[17]
|
R. Tafler, M. K. Herbert, R. F. Schmidt and K. H. Weis, “Small reduction of capsaicin-induced neurogenic in- flammation in human forearm skin by the glucocorticoid prednicarbate”, Agents Actions, Vol. 38, 1993, pp. C31- C34.
|
[18]
|
J. Wallengren, “Vasoactive peptides in the skin”, J Invest Dermatol Symp Proc., Vol. 2, No. 1, 1997, pp. 49-55.
|
[19]
|
A. M. Schabauer and T. W. Rooke, “Cutaneous laser Doppler flowmetry: applications and findings”, Mayo Clin Proc, Vol. 69, No. 6, 1994, pp. 564-74.
|
[20]
|
A. Fullerton, M. Stucker, K. P. Wilhelm, K. Wardell, C. Anderson, T. Fischer, G. E. Nilsson and J. Serup, “Guidelines for visualization of cutaneous blood flow by laser Doppler perfusion imaging. A report from the Stan- dardization Group of the European Society of Contact Dermatitis based upon the HIRELADO European com- munity project”, Contact Dermatitis, Vol. 46, No. 3, 2002a, pp. 129-140.
|
[21]
|
S. Kubli, B. Waeber, A. Dalle-Ave and F. Feihl, “Repro- ducibility of laser Doppler imaging of skin blood flow as a tool to assess endothelial function”, J Cardiovasc Phar- macol, Vol. 36, No. 5, 2000, pp. 640-648.
|
[22]
|
A. Fullerton, B. Rode and J. Serup, “Studies of cutaneous blood flow of normal forearm skin and irritated forearm skin based on high-resolution laser Doppler perfusion imaging (HR-LDPI)”, Skin Res Technol, Vol. 8, No. 1, 2002b, pp. 32-40.
|
[23]
|
B. J. Van der Schueren, J. N. de Hoon, F. H. Vanmolkot, A. Van Hecken, M. Depre, S. A. Kane, I. De Lepeleire and S. R. Sinclair, “Reproducibility of the capsaicin-in- duced dermal blood flow response as assessed by laser Doppler perfusion imaging”, Br J Clin Pharmacol, Vol. 64, No. 5, 2007, pp. 580-590.
|
[24]
|
P. Gazerani, O. K. Andersen and L. Arendt-Nielsen, “A human experimental capsaicin model for trigeminal sen- sitization, Gender-specific differences”, Pain, Vol. 118, No. 1-2, 2005, pp. 155-163.
|
[25]
|
T. A. Munce and W. Larry Kenney, “Age-Specific Skin Blood Flow Responses to Acute Capsaicin” Journal of Gerontology, Vol. 58A, No. 4, 2003, pp. 304-310.
|